KOREA ARLICO PHARM CO.,LTD. financial statements, including revenue, expenses, and profit
The total revenue of 260660 for the last quarter is 52.33 B KRW, and it's 7.19% higher compared to the previous quarter. The net income of Q4 24 is -1.75 B KRW.